ArticleO&G open2026
Oxytocin Dosing Intensity and Labor Induction Outcomes by Maternal Body Mass Index.
Article in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine associations between oxytocin dosing intensity and maternal outcomes-cesarean delivery and postpartum hemorrhage (PPH)-by body mass index (BMI).
methodsThis retrospective cohort study included singleton births from 2013 to 2022 at a large tertiary hospital among individuals receiving oxytocin for labor induction. Delivery BMI was classified as normal weight (18.5-24.9), overweight (25-29.9), class I-II obesity (30-39.9), and class III obesity (40 or above). Maximum oxytocin dose rate (milliunits per minute) was categorized into quartiles. Modified Poisson regression models, stratified by BMI, estimated risk ratios (RRs) for cesarean delivery and PPH, with adjustment for oxytocin exposure duration, insurance, maternal age, parity, gestational comorbidities, cervical status, gestational age, fetal sex, and birth weight.
resultsAmong 20,215 deliveries, 16.9% were to individuals with normal weight, 43.1% to individuals with overweight, 35.1% to individuals with class I-II obesity, and 4.9% to individuals with class III obesity. Maximum oxytocin dose and exposure duration increased with BMI. Individuals in the highest oxytocin quartile (more than 18 milliunits/min) had elevated risk of cesarean delivery and PPH compared with individuals in the lowest two quartiles; associations were partially attenuated after adjustment. Risks associated with highest-quartile dosing were greater for those with normal weight (adjusted RR for cesarean delivery 1.8 [95% CI, 1.5-2.2]; PPH 3.0 [95% CI, 1.7-5.4]) than for those with obesity (cesarean delivery 1.2 [95% CI, 1.0-1.5], class III; PPH 1.6 [95% CI, 1.2-2.0], any class). Among individuals with overweight or obesity, third-quartile dosing was not associated with increased PPH risk.
conclusionElevated BMI was associated with greater oxytocin requirements, but risks associated with increased dosing were attenuated in individuals with higher BMI. Tailored dosing strategies may improve labor efficacy and maternal safety.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.